Recurrent infections on extended treatment

Nephrada · IgA nephropathy

MI-2026-0812CriticalEscalatedOverdueEscalatedSafety

FAFatima Al-SayedMedical Information Lead

Restricted — potential adverse event

Access limited to Medical Information and Safety roles. Details are captured minimally and routed to pharmacovigilance per SOP-PV-014. AI features are disabled for this record (PRD §27.7).

Received: 14 Sept 2026, 08:12 UTC
Channel: MSL
Requestor type: HCP
Country / region / team: Germany · Europe · MI Europe
Category: Safety
Response type: Custom response
Owner: FAFatima Al-Sayed
Due: 15 Sept 2026, 08:12 UTC
Responded: —
Quality review: Pending
Related insight: INS-0058
Related standard response: None matched (topic-keyword match)

Workflow

12-stage inquiry workflow (PRD §16). Advancing records an audit event.

Received
Triage
Assigned
In progress
5Escalated
6Draft response
7Medical review
8Quality review
9Sent
10Follow-up required
11Closed
12Archived

Current stageEscalatedDemo action — not persisted

SLA

Critical: 24 h target · Routine 120 h / Urgent 48 h / Critical 24 h

SLA hours

Elapsed

28 h

and counting

Breached by

4 h

100%

Timeline

14 Sept 2026, 08:12 UTC
Received via MSL
HCP · Germany
14 Sept 2026, 08:12 UTC
Triage and assignment
Urgency Critical · assigned to MI Europe
14 Sept 2026, 08:12 UTC
Escalated
Safety flag — routed to pharmacovigilance
15 Sept 2026, 08:12 UTC
SLA due (24 h)
15 Sept 2026, 12:00 UTC
Current status: Escalated
Overdue by 4 h

Draft response

Restricted record

AI suggestion disabled — safety-flagged inquiries are not interpreted by AI (PRD §27.7).

Draft response

Audit history

Timestamp	Action	User	Field	Change	Reason	Source	Event
14 Sept 2026, 08:14 UTC	Update	Fatima Al-Sayed	status	Triage → Escalated	Safety flag; PV notified	UI	AUD-001802

Data lineage: MI inquiry platform (IRMS, INT-05) · received 14 Sept 2026 · hourly sync.